A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

NCT05775523 · clinicaltrials.gov ↗

RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Hormone Deficiency

Interventions

DRUG: No intervention

Sponsor

Ascendis Pharma Endocrinology Division A/S